MedTrace Logo

Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use- Electronic Spanish Platform

NCT05476588 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2026-01-26

No results posted yet for this study

Summary

The goal of this study is to validate the TAPS-ESP as a screen and assessment that can be used in primary care for the screening and treatment of substance use.

Conditions

  • Tobacco Use
  • Alcohol Abuse
  • Prescription Drug Abuse
  • Substance Use

Interventions

OTHER

Screening

Screening and validation of assessment tool translated into Spanish

Sponsors & Collaborators

  • COG Analytics

    collaborator OTHER

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Katherine Sanchez, PhD · Baylor Scott and White Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-15
Primary Completion
2024-03-14
Completion
2024-03-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05476588 on ClinicalTrials.gov